Landmark gene therapy poised for US approval
Nature Reviews Drug Discovery 16, 739 (2017).
doi:10.1038/nrd.2017.212
Author: Chris Morrison
The FDA is weighing the fate of Spark Therapeutics' voretigene neparvovec, potentially the first among a wave of new gene therapies.
Source: Nature Reviews Drug Discovery - Category: Drugs & Pharmacology Authors: Chris Morrison Tags: News and Analysis Source Type: research